Lung Cancer Screening Eligibility Assessment
The primary purpose of this study evaluate if different messaging impacts response rates to a brief survey (i.e., the simplified eligibility tool) that is designed to estimate pack-year eligibility for lung cancer screening (LCS). This will help inform the best way to increase response rates to the tool in future intervention studies designed to increase LCS, and expand upon survey methodology in general.
Checked against the public recordLast updated May 31, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Interventions being studied
- Behavioral: Framed Introductory Message A; Behavioral: Framed Introductory Message B; Behavioral: Framed Introductory Message C; Behavioral: Framed Tobacco Use Message A; Behavioral: Framed Tobacco Use Message B; Behavioral: Financial Incentive
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. meet age eligibility (50-80 years old) for LCS based on 2021 USPSTF guidelines; and 2. have completed at least one primary care visit at Penn Medicine in 2020-2025 Exclusion Criteria: 1. have a documented history of lung cancer; 2. have a documented history of completing LCS at Penn Medicine; 3. are listed as not wanting to be contacted or solicited for research; or 4. do not otherwise meet inclusion criteria.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of PennsylvaniaPhiladelphia, Pennsylvania
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 31, 2025. Always confirm current availability with the study team.